Updated:
Cardiac Insight
Cardiac Insight is based in Bellevue and was founded in 2013; the profile covers headquarters, registration, AUM band and key contacts for private-markets...
Overview
Cardiac Insight improves patient care with innovative ECG solutions, helping clinicians deliver accurate, life-saving cardiac diagnostics
General information
Year founded
2013
Location
Region
North America
Country
United States
City
Bellevue
Corporate office
Bellevue, WA, United States
Principals
Dr. Dave Hadley
Co-Founder
Dr. Vic Froelicher
Co-Founder
Sector focus
Frequently asked questions
Who are the founders and how do they divide responsibilities at Cardiac Insight?
Cardiac Insight was co-founded by Dr. Dave Hadley and Dr. Vic Froelicher. Hadley, a Caltech Ph.D., previously co-founded Sierra Geophysics and focuses on algorithm development and product innovation. Froelicher is a cardiologist who contributed to the Stanford Criteria for ECG interpretation, shaping the clinical framework behind the Cardea 20/20 system (per the firm, 2023).
What are the primary FDA-cleared products and what conditions do they diagnose?
Cardiac Insight's two FDA-cleared products are the Cardea SOLO (cleared 2017) and Cardea 20/20. Cardea SOLO is a 7-day wearable ambulatory ECG sensor with software-assisted analysis for detecting arrhythmias. Cardea 20/20 is a handheld 12-lead ECG system designed to identify hidden cardiac conditions in athletes, using the International Consensus Criteria and achieving a low false-positive rate of ~2% (per the firm, 2023).
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: